Abstract
Current practice favors serotesting adolescents with a negative history of chickenpox rather than offering presumptive vaccination. Recent epidemiologic data from Greece indicate that a high proportion of adolescents (21.5%) are susceptible to chickenpox. We assessed the reliability of negative varicella history in relation to type of exposure in 311 children and 283 adolescents. In children with social or unknown exposure to varicella, a negative history had a high negative predictive value (NPV = 73.5), supporting the clinical practice of presumptive vaccination. Conversely, children with a negative history and household exposure had a low NPV (13.8), suggesting that pre-vaccination serologic testing is warranted. In conclusion, based on our local epidemiologic data, presumptive varicella vaccination should be offered to all adolescents with the exception of the subgroup of adolescents with household exposure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- IgG:
-
Immunoglobulin G
- NPV:
-
Negative predictive value
- VZV:
-
Viral zoster virus
References
Arvin AM (2000) Varicella zoster virus. In: Behrman R, Kliegman. R, Jensen H (eds) Nelson textbook of pediatrics, 15th edn. WB Saunders, Philadelphia, pp 1413–1418
Centers of Diseases Control and Prevention (1999) Prevention of varicella: updates recommendations of the Advisory Committee on immunization practices (ACIP). MMWR 48:1–5
Choo PW, Donahue JG, Manson JE, Platt R (1995) The epidemiology of varicella and its complications. J Infect Dis 172:706–712
Committee on Infectious Diseases, American Academy of Pediatrics (1995) Recommendations for the use of live attenuated varicella vaccine. Pediatrics 95:791–796
Coplan P, Coplan P, Black S, Rojas C, Shinefield H, Ray P, Lewis E, Guess H (2001) Incidence and hospitalization rates of varicella and herpes zoster before varicella vaccine introduction: A baseline assessment of the shifting epidemiology of varicella disease. Pediatr Infect Dis J 20:641–645
Corbeel L (2004) Congenital varicella syndrome, editorial comment. Eur J Pediatr 163:345–346
Hanslik T, Boelle PY, Schwarzinger M, Carrat F, Freedberg KA, Valleron AJ, Flahault A (2003) Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination. Vaccine 21:3614–3622
Harel Z, Ipp L, Riggs S, Vaz R, Flanagan P (2001) Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox. J Adolesc Health 28:26–29
Heininger U (2002) New immunization recommendations in Germany. Arch Dis Child 86:84
Heininger U, Baer G, Bonhoeffer F, Schaad UB (2005) Reliability of varicella history in children and adolescents. Swiss Med Wkly 135:252–255
Holmes CN (2005) Predictive value of a history of varicella infection. Can Fam Physician 51:60–65
Jakson MA, Burry VF, Olson LC (1992) Complications of varicella requiring hospitalization in previously healthy children. Pediatr Infect Dis J 11:441–445
Katsafadou A, Ferentinos G, Constantopoulos A, Papaevangelou V (2007) Epidemiology of varicella in school-aged Greek children before the implementation of universal vaccination. Eur J Clin Microbiol Infect Dis. DOI 10.1007/s10096-007-0418-x. Epub 16 Nov 2007
Kavaliotis J, Petridou S, Karabaxoglou D (2003) How reliable is the history of chickenpox? Varicella serology among children up to 14 years of age. Int J Infect Dis 7:274–277
Lieu TA, Finkler LJ, Sorel ME, Black SB, Shinefield HR (1995) Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents. Pediatrics 95:632–638
Lieu TA, Black SB, Takahashi H, Ray P, Capra AM, Shinefield HR, Adler NE (1998) Varicella serology among school age children with a negative or uncertain history of chickenpox. Pediatr Infect Dis J 17:120–125
Matthew MD, Mitesh SP, Achamyeleh G (2004) Decline in varicella-Related hospitalizations and adults after introduction of varicella vaccine in United States. Pediatrics 114:786–792
Miller E, Marshall R, Vurdien J (1993) Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 4:222–230
Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, Tischer A, Andrews N, Berbers G, Gabutti G, Gay N, Jones L, Jokinen S, Kafatos G, de Aragón MV, Schneider F, Smetana Z, Vargova B, Vranckx R, Miller E (2007) The comparative sero-epidemiology of varicella-zoster virus in 11 countries in the European region. Vaccine 25:7866–7872
Nguyen HQ, Jumaan AO, Seward JF (2005) Decline in mortality due to varicella and implementation of varicella vaccination in the United States. N Engl J Med 352:450–458
Pinot de Moira A, Nardone A, ESEN2 group (2005) Varicella zoster virus vaccination policies and surveillance strategies in Europe. Eurosurveillance 10:3–4
Ronan K, Wallace MR (2001) The utility of serologic testing for varicella in an adolescent population. Vaccine 19:4700–4702
Seward JF (2001) Update on varicella. Pediatr Infect Dis J 20:619–621
Acknowledgements
We would also like to thank Vianex for supporting us financially for the serologic testing.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Katsafadou, A., Kallergi, K., Ferentinos, G. et al. Presumptive varicella vaccination is warranted in Greek adolescents lacking a history of disease or household exposure. Eur J Pediatr 168, 23–25 (2009). https://doi.org/10.1007/s00431-008-0701-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-008-0701-6